| Mallory J Melby, PA | |
|
1662 Higdon Ferry Rd Ste 300, Hot Springs, AR 71913-6982 | |
| (501) 321-2663 | |
| Not Available |
| Full Name | Mallory J Melby |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 1662 Higdon Ferry Rd Ste 300, Hot Springs, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891209086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA-749 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Hot Springs | Hot springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chi St Vincent Medical Group Hot Springs | 3971673716 | 151 |
News Archive
The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.
Ricerca Biosciences, LLC, announced today its execution of a purchase agreement to acquire the Discovery and Preclinical business of MDS Pharma Services with facilities in Bothell, Washington; Lyon, France; and Taipei, Taiwan. Company headquarters will remain in Concord, Ohio.
Prediabetes and Diabetes increasingly consume the healthcare community and remain priority areas that require immediate attention.
Diets rich in potassium may help protect the heart and kidney health of patients with type 2 diabetes, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mallory J Melby, PA Po Box 21850, Hot Springs, AR 71903-1850 Ph: (501) 321-2663 | Mallory J Melby, PA 1662 Higdon Ferry Rd Ste 300, Hot Springs, AR 71913-6982 Ph: (501) 321-2663 |
News Archive
The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.
Ricerca Biosciences, LLC, announced today its execution of a purchase agreement to acquire the Discovery and Preclinical business of MDS Pharma Services with facilities in Bothell, Washington; Lyon, France; and Taipei, Taiwan. Company headquarters will remain in Concord, Ohio.
Prediabetes and Diabetes increasingly consume the healthcare community and remain priority areas that require immediate attention.
Diets rich in potassium may help protect the heart and kidney health of patients with type 2 diabetes, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
› Verified 3 days ago
Hannah W Jeane, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Mercy Ln Ste 401, Hot Springs, AR 71913 Phone: 501-623-5220 | |
Neysa S Ellis, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1662 Higdon Ferry Rd, Suite 300, Hot Springs, AR 71913 Phone: 501-321-2663 Fax: 501-321-9705 | |
Dallas M Bondhus, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln Ste 505, Hot Springs, AR 71913 Phone: 501-623-2426 Fax: 501-623-2405 | |
Miss Emily L Garza, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1455 Higdon Ferry Rd Ste B, Hot Springs, AR 71913 Phone: 501-623-2731 Fax: 501-623-1660 | |
Mr. Patrick A Litster, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Mcgowan Ct, Hot Springs, AR 71913 Phone: 501-525-9675 Fax: 501-525-7059 | |
Emily Vaughan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1629 Airport Rd Ste B, Hot Springs, AR 71913 Phone: 501-767-0075 | |
Mr. David Michael Moore, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1662 Higdon Ferry Road, Ste 300, Hot Springs, AR 71913 Phone: 501-321-2663 |